Abolis Biotechnologies - Bio-Synthesis Architects, is a leading European developer of precision fermentation microbial strains. We “make microbes”, and the microbes we develop make the molecules that our clients need. Working at the service of market leaders in Pharma, Cosmetics, Food and Chemicals, we enable our clients to broaden their product and ingredient portfolio with sustainable alternatives that are bio-based, renewable, sustainable, and biodiversity-friendly. Our core competencies in bioinformatics, genetics, fermentation, robotics and advanced analytics, together with our proprietary tools and professional service mindset, enable us to develop novel precision fermentation processes for existing or "new to nature" molecules and innovative functionalities. We offer a risk-managed and safe path to market, strengthen by solid economics.